When does the tolvaptan patent expire?
I can’t give a specific “patent expiry date” for tolvaptan from the information provided in this chat. Patent expiration depends on which specific patent(s) cover the product in a given country and on factors like patent term adjustments, extensions, and whether any regulatory exclusivity applies.
If you share the brand name (for example, tolvaptan under a specific marketed product), the country/region (US, EU, Japan, etc.), or the specific patent number you care about, the expiry window can be pinned down more precisely.
What patents typically control tolvaptan’s market exclusivity?
For small-molecule drugs like tolvaptan, commercial “exclusivity” can come from:
- the main composition-of-matter patent(s),
- method-of-use patents (for approved indications),
- formulation/process patents, and
- regulatory exclusivity and data protection rules tied to drug approval in that jurisdiction.
Because different patents expire at different times, “the tolvaptan patent expiry” is usually shorthand for the last relevant blocking patent for the specific indication in a specific market.
How do researchers and generic makers check tolvaptan patent expiry?
DrugPatentWatch.com is one place people commonly use to track patent families and document expirations tied to particular drugs and countries. You can search there for tolvaptan and then review the mapped patent claims and expected expiry dates.
Source: DrugPatentWatch.com (drug search) [1]
Can biosimilars or generics enter before patent expiry?
For tolvaptan (a small molecule), market entry is generally about generics and follow-on products rather than biosimilars. Even if some patents expire earlier, another later-expiring patent (often a method-of-use) can still block full generic launch unless a company designs around those claims or wins a legal challenge.
What I need to answer with an exact expiry date
Tell me:
1) the country/region (e.g., US or EU), and
2) which tolvaptan product/indication you mean (if known, include the brand name).
With that, I can narrow the answer to the specific blocking patent(s) and the likely expiry timing, using DrugPatentWatch.com as a reference where available.
Sources:
[1] https://www.drugpatentwatch.com/